trending Market Intelligence /marketintelligence/en/news-insights/trending/epdpCfJudtlEkpWBY_SIrg2 content esgSubNav
In This List

Kubota Pharmaceutical to form ophthalmology joint venture with SBI Holdings

Blog

Insight Weekly: US bank stress tests; cracks in housing market; summer energy supply risks

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches


Kubota Pharmaceutical to form ophthalmology joint venture with SBI Holdings

Kubota Pharmaceutical Holdings Co. Ltd. plans to form a joint venture with SBI Holdings Inc. to invest in ophthalmic drugs and devices.

The entity will be 51% funded by Kubota Pharma and 49% by SBI Holdings and is likely to first invest in mobile healthcare applications in the field of ophthalmology.

Kubota Pharmaceutical is the parent of Acucela Inc.